Management and Retention of Clinical Trial Data: Archiving and Confidentiality

Data management and retention sit at the center of any effective, compliant clinical trial. As medical research intensifies and medical devices grow more complex, clinical study sponsors face a twofold challenge: guaranteeing the scientific integrity of the data they collect while ensuring optimal protection of that data. Clinical data calls for a structured approach that respects both scientific requirements and regulatory frameworks such as the GDPR. Good data management helps you optimize the statistical analysis of results and also strengthens the security of information about trial participants.

💡 Want to secure your clinical data? Request a personalized demo →

Best practices for clinical data management

The quality of a clinical trial depends in large part on the reliability of its data. To ensure that reliability, you need to put several essential practices in place:

Standardized processes: A clear protocol for collecting and processing data keeps the data consistent and makes later analysis easier.

Quality control must be systematic at every stage of the data management process. That means regular checks to detect and correct inconsistencies or missing data.

Traceability is another requirement. You must document, date and sign every change made to the data to guarantee the integrity of the research process.

Today, best practices for clinical data security include securing storage systems, anonymizing personal information and setting up strict access rights, which you need to protect participants' sensitive data.

The digitalization of clinical trials has also revolutionized data management. EDC (Electronic Data Capture) systems allow structured, secure data collection. An eCRF/EDC platform is a major asset for clinical data security, providing strict access control, a complete audit trail and built-in regulatory compliance. eClinical platforms give you a global view of the trial and make data monitoring easier.

Automating consistency checks and setting up alerts brings a major improvement in clinical data quality. These technologies help reduce errors and speed up statistical analysis.

Regulatory requirements: GDPR and EMA guidelines

Regulatory compliance is an essential part of clinical trial data management. The General Data Protection Regulation (GDPR) imposes strict obligations on the processing of personal data in health research.

In France, the CNIL plays a leading role in overseeing compliance with these regulations. Among other things, it sets the conditions for obtaining participants' consent and the rules for protecting their data.

Guidelines from the European Medicines Agency (EMA) complete this regulatory framework by setting out the standards expected for the documentation and retention of clinical data.

To comply with data management regulations, you need to:

• Appoint a data protection officer (DPO)
• Carry out data protection impact assessments (DPIAs)
• Put appropriate technical and organizational measures in place

You can find out more in the CNIL's official documents: GDPR: data protection impact assessment (DPIA).

💡 Looking for the right EDC platform for your study? Read the comparison

Roles and responsibilities in data management

Effective data management in a clinical study rests on a clear division of responsibilities:

The sponsor holds overall responsibility for the trial and must make sure the data management systems meet regulatory requirements.

Data managers oversee data collection, cleaning and validation throughout the clinical trial.

Clinical monitors carry out data monitoring and make sure the data entered matches the source documents.

Retention periods for clinical trial data

You must archive the essential documents of a clinical study under optimal security conditions. Store them in a restricted-access environment, protected against physical and IT risks. Rigorous retention of this kind lets you meet the audit and inspection requirements of health authorities.

Retention and archiving periods for clinical trial data by type of research.

| Type of research | Data concerned | Retention period in the active database | Archiving period |

| Research involving human participants (RIPH) | Participant data | Up to 2 years after the last publication or until the final report is signed | Archiving in line with current regulations |

| Interventional research | Professionals' data | Maximum 15 years after the end of the last study | According to current regulations |

| Non-interventional research | Participant data | Up to 2 years after the last publication or signature of the final report | Maximum 20 years |

| Research on data already collected | Participant data | Up to 2 years after the last publication or signature of the final report | Maximum 20 years |

| Studies requiring access to PMSI data | Data in a secure platform | Time needed for the study + maximum 2 years after the last publication | Cannot be exported outside the platform |

| Signed consent forms | Original documents | Kept in the active database | 30 years |

ℹ️ Note: These periods follow the CNIL reference methodologies (MR-001, MR-003, MR-004). For research that does not follow these methodologies, the CNIL assesses the period set by the data controller when it reviews the authorization request.